Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB25FRTN8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,472
Award facts
- Contract value 100% obligated
- $50,471.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,471.94 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen cartridges. The contract utilizes firm fixed pricing with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors and healthcare solutions providers, maintains a substantial federal contracting presence supporting military and veteran healthcare systems. The company's IDC with DLA encompasses a broad portfolio of pharmaceutical products and medical supplies including specialty medications, vaccines, brand-name and generic drugs, and medical devices across multiple therapeutic domains. SKYRIZI is a biologic medication used in the treatment of various dermatological and immunological conditions, and this award reflects the company's ongoing role as a critical vendor in the Defense Health Agency's medical supply chain. The DLA is concurrently planning next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple anticipated awards across separate regions, positioning AmerisourceBergen to continue serving federal healthcare customers including the U.S. Coast Guard and other government health systems.
Quick answers
Who was awarded contract SPE2DB25FRTN8?
SPE2DB25FRTN8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FRTN8 worth?
The government has obligated $50,472 on SPE2DB25FRTN8.
Is contract SPE2DB25FRTN8 an order under another contract?
Yes. SPE2DB25FRTN8 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRTN8 competed?
The extent of competition for SPE2DB25FRTN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award